Sergey Badalyan, Medical Oncology Resident at Yeolyan Hematology and Oncology Center, Publishing Editor at OncoDaily, shared a post on LinkedIn:
“Got 15 minutes to spare over your Monday lunch? I’ve got something you might actually enjoy.
I recently sat down with Juan Manuel O´Connor, Head of GI Tumors at IAF (Instituto Alexander Fleming), to talk through his ESMO2025 presentation on locoregional digestive neuroendocrine carcinoma, and the conversation turned out to be refreshingly real.
Instead of running through slides, we talked about how these cases feel in practice: when pathology isn’t crystal clear, when tumor location quietly changes the whole plan, and when treatment decisions are less about guidelines and more about sequencing and judgment. It’s the kind of discussion that mirrors what actually happens in MDT meetings, not just what’s written in reviews.
The interview is short, focused, and easy to listen to, something you can finish between emails or during a lunch break without needing to pause and rewind every two minutes.
If you’re seeing NEC patients (or might one day), I’d be curious what you find most challenging in practice. Always interesting to hear how others navigate these gray zones.”
More posts featuring Sergey Badalyan.